New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 13, 2014
07:32 EDTPOZN, HZNPHorizon Pharma, POZEN announce USPTO Notice of Allowance for VIMOVO
Horizon Pharma (HZNP) announced that POZEN (POZN), has received a Notice of Allowance from the United States Patent and Trademark Office for U.S. patent application number 14/045,156 entitled "Pharmaceutical Compositions for the Coordinated Delivery of NSAIDs" that covers Horizon and POZEN'S U.S. approved product VIMOVO delayed release tablets.
News For HZNP;POZN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 26, 2015
07:28 EDTHZNPHorizon Pharma price target raised to $40 from $32 at UBS
Subscribe for More Information
June 23, 2015
07:36 EDTHZNPJMP Securities to hold a conference
Subscribe for More Information
07:12 EDTHZNPHorizon Pharma announces notice of allowance with claims covering Ravicti
Horizon Pharma announced that it has received from the United States Patent and Trademark Office a Notice of Allowance for U.S. patent application number 13/775,000, entitled "Methods of Therapeutic Monitoring of Nitrogen Scavenging Drugs" that covers Horizon's U.S. approved product Ravicti Oral Liquid.
June 22, 2015
07:31 EDTPOZNPOZEN names Mark Glickman as Chief Commercial Officer
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use